<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04876495</url>
  </required_header>
  <id_info>
    <org_study_id>VRE1516-1375</org_study_id>
    <nct_id>NCT04876495</nct_id>
  </id_info>
  <brief_title>The Effects of Whey, Rice and Potato pRotein isOlates on appeTite rEgulatIoN in Healthy Men</brief_title>
  <acronym>PROTEIN</acronym>
  <official_title>Comparative Effects of Dairy and Plant-based Protein Intake on Acute Glucose Homeostasis and Appetite Regulation in Healthy Men</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Westminster</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Coventry University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Westminster</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      INTRODUCTION: Global protein consumption has been increasing for decades due to changes in&#xD;
      socio-economic demographics and consumer trends towards higher protein intake, which may be&#xD;
      related to their health benefits in performance nutrition and appetite regulation. The&#xD;
      additional intake of protein often occurs in the form of supplements. One of the main&#xD;
      ingredients used in sports and weight loss supplements are animal-derived proteins such as&#xD;
      whey, which are of high quality, containing all the essential amino acids required in human&#xD;
      nutrition with a high absorption rate. However, whey protein has a high environmental&#xD;
      footprint, and it may contribute to insulin resistance in susceptible groups (e.g. obese,&#xD;
      T2DM, insulin resistant, or those with sarcopenic obesity).&#xD;
&#xD;
      Rice and potato protein isolates are high-quality plant proteins containing all essential&#xD;
      amino acids comparably to whey protein. These plant-derived proteins may provide a more&#xD;
      sustainable and accessible alternative to animal-derived proteins for appetite regulation and&#xD;
      weight management.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intervention study with three treatment groups in a randomised, single-blind, triple&#xD;
      crossover design.&#xD;
&#xD;
      Study population: Healthy male participants will receive three different isocaloric and&#xD;
      -volumetric protein shakes prepared using whey, rice and potato protein powders on different&#xD;
      trial days with at least a one-week washout period apart.&#xD;
&#xD;
      Biological samples (blood and saliva samples) are collected at various time points during the&#xD;
      visit. Blood samples are collected at baseline 10 min prior (T-10), then at 30 min (T30), 60&#xD;
      min (T60), 120 min (T120) and at 180 min (T180) after protein shake consumption. Saliva&#xD;
      samples are collected at baseline (T-10), then at every 30 minutes following protein shake&#xD;
      consumption (T30, T60, T90, T120, T150, T180). In addition, pertinent questionnaires Visual&#xD;
      Analogue Scale [VAS] for the assessment of satiety and VAS for the assessment of protein&#xD;
      shakes' perception will be collected at T-10, T30, T60, T90, T120, T150, T180 and at T0,&#xD;
      respectively&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 20, 2018</start_date>
  <completion_date type="Actual">February 19, 2021</completion_date>
  <primary_completion_date type="Actual">February 19, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>single-blind, randomised, triple crossover</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on glucose levels (T-10)</measure>
    <time_frame>Glucose measured 10 minutes prior to protein shake consumption</time_frame>
    <description>Marker: glucose (mmol/L)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on glucose levels (T30)</measure>
    <time_frame>Glucose measured 30 minutes post protein shake consumption</time_frame>
    <description>Marker: glucose (mmol/L)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on glucose levels (T60)</measure>
    <time_frame>Glucose measured 60 minutes post protein shake consumption</time_frame>
    <description>Marker: glucose (mmol/L)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on glucose levels (T120)</measure>
    <time_frame>Glucose measured 120 minutes post protein shake consumption</time_frame>
    <description>Marker: glucose (mmol/L)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on glucose levels (T180)</measure>
    <time_frame>Glucose measured 180 minutes post protein shake consumption</time_frame>
    <description>Marker: glucose (mmol/L)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on insulin levels (T-10)</measure>
    <time_frame>Insulin measured 10 minutes prior to protein shake consumption</time_frame>
    <description>Marker: insulin (ng/mL)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on insulin levels (T30)</measure>
    <time_frame>Insulin measured 30 minutes post protein shake consumption</time_frame>
    <description>Marker: insulin (ng/mL)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on insulin levels (T60)</measure>
    <time_frame>Insulin measured 60 minutes post protein shake consumption</time_frame>
    <description>Marker: insulin (ng/mL)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on insulin levels (T120)</measure>
    <time_frame>Insulin measured 120 minutes post protein shake consumption</time_frame>
    <description>Marker: insulin (ng/mL)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on insulin levels (T180)</measure>
    <time_frame>Insulin measured 180 minutes post protein shake consumption</time_frame>
    <description>Marker: insulin (ng/mL)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on glucagon-like peptide 1 levels (T-10)</measure>
    <time_frame>Glucagon-like peptide 1 measured 10 minutes prior to protein shake consumption</time_frame>
    <description>Markers: glucagon-like peptide 1 (pM)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on glucagon-like peptide 1 levels (T30)</measure>
    <time_frame>Glucagon-like peptide 1 measured 30 minutes post protein shake consumption</time_frame>
    <description>Markers: glucagon-like peptide 1 (pM)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on glucagon-like peptide 1 levels (T60)</measure>
    <time_frame>Glucagon-like peptide 1 measured 60 minutes post protein shake consumption</time_frame>
    <description>Markers: glucagon-like peptide 1 (pM)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on glucagon-like peptide 1 levels (T120)</measure>
    <time_frame>Glucagon-like peptide 1 measured 120 minutes post protein shake consumption</time_frame>
    <description>Markers: glucagon-like peptide 1 (pM)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on glucagon-like peptide 1 levels (T180)</measure>
    <time_frame>Glucagon-like peptide 1 measured 180 minutes post protein shake consumption</time_frame>
    <description>Markers: glucagon-like peptide 1 (pM)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on peptide tyrosine tyrosine levels (T-10)</measure>
    <time_frame>Peptide tyrosine tyrosine measured 10 minutes prior to protein shake consumption</time_frame>
    <description>Markers: peptide tyrosine tyrosine (pg/mL)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on peptide tyrosine tyrosine levels (T30)</measure>
    <time_frame>Peptide tyrosine tyrosine measured 30 minutes post protein shake consumption</time_frame>
    <description>Markers: peptide tyrosine tyrosine (pg/mL)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on peptide tyrosine tyrosine levels (T60)</measure>
    <time_frame>Peptide tyrosine tyrosine measured 60 minutes post protein shake consumption</time_frame>
    <description>Markers: peptide tyrosine tyrosine (pg/mL)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on peptide tyrosine tyrosine levels (T120)</measure>
    <time_frame>Peptide tyrosine tyrosine measured 120 minutes post protein shake consumption</time_frame>
    <description>Markers: peptide tyrosine tyrosine (pg/mL)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on peptide tyrosine tyrosine levels (T180)</measure>
    <time_frame>Peptide tyrosine tyrosine measured 180 minutes post protein shake consumption</time_frame>
    <description>Markers: peptide tyrosine tyrosine (pg/mL)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on ghrelin levels (T-10)</measure>
    <time_frame>Ghrelin (pg/mL) measured 10 minutes prior to protein shake consumption</time_frame>
    <description>Markers: ghrelin (pg/mL)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on ghrelin levels (T30)</measure>
    <time_frame>Ghrelin (pg/mL) measured 30 minutes post protein shake consumption</time_frame>
    <description>Markers: ghrelin (pg/mL)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on ghrelin levels (T60)</measure>
    <time_frame>Ghrelin (pg/mL) measured 60 minutes post protein shake consumption</time_frame>
    <description>Markers: ghrelin (pg/mL)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on ghrelin levels (T120)</measure>
    <time_frame>Ghrelin (pg/mL) measured 120 minutes post protein shake consumption</time_frame>
    <description>Markers: ghrelin (pg/mL)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on ghrelin levels (T180)</measure>
    <time_frame>Ghrelin (pg/mL) measured 180 minutes post protein shake consumption</time_frame>
    <description>Markers: ghrelin (pg/mL)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on appetite (T-10)</measure>
    <time_frame>Visual Analogue Scale for Appetite (VAS-A) collected immediately prior to protein shake consumption</time_frame>
    <description>Subjective analysis including: Visual Analogue Scale for Appetite (VAS-A). Scores range from 0 to 100 (the higher the score the greater the level of appetite)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on appetite (T30)</measure>
    <time_frame>Visual Analogue Scale for Appetite (VAS-A) collected 30 minutes after protein shake consumption</time_frame>
    <description>Subjective analysis including: Visual Analogue Scale for Appetite (VAS-A). Scores range from 0 to 100 (the higher the score the greater the level of appetite)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on appetite (T60)</measure>
    <time_frame>Visual Analogue Scale for Appetite (VAS-A) collected 60 minutes after protein shake consumption</time_frame>
    <description>Subjective analysis including: Visual Analogue Scale for Appetite (VAS-A). Scores range from 0 to 100 (the higher the score the greater the level of appetite)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on appetite (T90)</measure>
    <time_frame>Visual Analogue Scale for Appetite (VAS-A) collected 90 minutes after protein shake consumption</time_frame>
    <description>Subjective analysis including: Visual Analogue Scale for Appetite (VAS-A). Scores range from 0 to 100 (the higher the score the greater the level of appetite)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on appetite (T120)</measure>
    <time_frame>Visual Analogue Scale for Appetite (VAS-A) collected 120 minutes after protein shake consumption</time_frame>
    <description>Subjective analysis including: Visual Analogue Scale for Appetite (VAS-A). Scores range from 0 to 100 (the higher the score the greater the level of appetite)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on appetite (T150)</measure>
    <time_frame>Visual Analogue Scale for Appetite (VAS-A) collected 150 minutes after protein shake consumption</time_frame>
    <description>Subjective analysis including: Visual Analogue Scale for Appetite (VAS-A). Scores range from 0 to 100 (the higher the score the greater the level of appetite)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on appetite (T180)</measure>
    <time_frame>Visual Analogue Scale for Appetite (VAS-A) collected 180 minutes after protein shake consumption</time_frame>
    <description>Subjective analysis including: Visual Analogue Scale for Appetite (VAS-A). Scores range from 0 to 100 (the higher the score the greater the level of appetite)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To assess the perception of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO®</measure>
    <time_frame>VAS for Palatability collected immediately after protein shake consumption</time_frame>
    <description>Subjective analysis including: Visual Analogue Scale for Palatability (VAS-P). Scores range from 0 to 100 (the higher the score the lower the palatability)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Appetite and General Nutritional Disorders</condition>
  <arm_group>
    <arm_group_label>Whey protein</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Whey protein isolate (45.5g total protein content)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Potato protein</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Potato protein isolate (45.3g total protein content)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rice protein</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Rice protein isolate (45.5g total protein content)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Whey protein isolate</intervention_name>
    <description>Instantized BiPRO® 50g (equiv. 45.5g of total protein) presented to participants in a form of a shake.&#xD;
Other ingredients in the whey protein shake:&#xD;
Tropicana Trop50 Orange Juice 207mL&#xD;
Water 43 mL&#xD;
Sucralose 0.5g&#xD;
The total energy 233.47Kcal.&#xD;
Participants instructed to consume the entire protein shake presented to them in 5 minutes on an empty stomach when attending the study.</description>
    <arm_group_label>Whey protein</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Potato protein isolate</intervention_name>
    <description>Solanic®100 48g (equiv. 45.3g of total protein) presented to participants in a form of a shake.&#xD;
Other ingredients in the potato protein shake:&#xD;
Tropicana Trop50 Orange Juice 250mL&#xD;
Sucralose 0.5g&#xD;
The total energy 233.46Kcal&#xD;
Participants instructed to consume the entire protein shake presented to them in 5 minutes on an empty stomach when attending the study.</description>
    <arm_group_label>Potato protein</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Rice protein isolate</intervention_name>
    <description>Oryzatein® Silk 90 50g (equiv. 45.5g of total protein) presented to participants in a form of a shake.&#xD;
Other ingredients in the rice protein shake:&#xD;
Tropicana Trop50 Orange Juice 183mL&#xD;
Water 67mL&#xD;
Sucralose 0.5g&#xD;
The total energy 233.43Kcal&#xD;
Participants instructed to consume the entire protein shake presented to them in 5 minutes on an empty stomach when attending the study.</description>
    <arm_group_label>Rice protein</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Males (18-65 years of age)&#xD;
&#xD;
          -  Healthy subjects&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  &lt;18 years or &gt;65 years&#xD;
&#xD;
          -  Consumption of &gt;21 units of alcohol/week&#xD;
&#xD;
          -  Dieters&#xD;
&#xD;
          -  Any allergies/health issues related to items being ingested&#xD;
&#xD;
          -  Any serious illnesses or those on medication&#xD;
&#xD;
          -  Any illness affecting taste or appetite&#xD;
&#xD;
          -  Any gastrointestinal disorders&#xD;
&#xD;
          -  Any eating disorders&#xD;
&#xD;
          -  Any depression/mental disorders&#xD;
&#xD;
          -  Smoking&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Participants' eligibility is based on self-representation of gender identity</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohammed Gulrez Zariwala, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Westminster</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Westminster</name>
      <address>
        <city>London</city>
        <state>Greater London</state>
        <zip>W1W 6UW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 28, 2021</study_first_submitted>
  <study_first_submitted_qc>May 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 6, 2021</study_first_posted>
  <last_update_submitted>May 2, 2021</last_update_submitted>
  <last_update_submitted_qc>May 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Westminster</investigator_affiliation>
    <investigator_full_name>Mohammed Gulrez Zariwala</investigator_full_name>
    <investigator_title>Professor of Translational Physiology</investigator_title>
  </responsible_party>
  <keyword>nutraceutical</keyword>
  <keyword>protein</keyword>
  <keyword>whey</keyword>
  <keyword>potato protein</keyword>
  <keyword>rice protein</keyword>
  <keyword>appetite</keyword>
  <keyword>satiety</keyword>
  <keyword>insulin</keyword>
  <keyword>glucose</keyword>
  <keyword>appetite hormone</keyword>
  <keyword>GLP-1</keyword>
  <keyword>PYY</keyword>
  <keyword>supplement</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nutrition Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

